Perspectives: Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder

Sponsor
University of Pittsburgh (Other)
Overall Status
Completed
CT.gov ID
NCT00902798
Collaborator
National Institute of Mental Health (NIMH) (NIH), Autism Speaks (Other), United States Department of Defense (U.S. Fed), Pennsylvania Department of Health (Other)
54
1
2
82
0.7

Study Details

Study Description

Brief Summary

This study will investigate and contrast the effects of two psychological treatments for adults with autism spectrum disorder. Cognitive Enhancement Therapy (CET) is a cognitive remediation intervention that aims to help adults with problems in thinking, planning, and socialization. Enriched Supportive Therapy (EST) is an individual supportive therapy that aims to help adults learn about their condition, manage their emotions and stress, improve their social skills, and cope with everyday problems.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Enhancement Therapy
  • Behavioral: Enriched Supportive Therapy
N/A

Detailed Description

Autism spectrum disorder (ASD) is characterized by marked impairments in social and non-social cognitive ability that persist well into adulthood and contribute to significant functional disability. The treatment of ASD has focused almost exclusively on children, and few empirically supported interventions are available to address the core cognitive and functional challenges individuals with ASD face as they transition to adulthood. This study will investigate and contrast the effects of two psychological treatments for adults with autism spectrum disorder. Cognitive Enhancement Therapy (CET) is a cognitive remediation intervention that aims to help adults with problems in thinking, planning, and socialization. Enriched Supportive Therapy (EST) is an individual supportive therapy that aims to help adults learn about their condition, manage their emotions and stress, improve their social skills, and cope with everyday problems.

Participation in this study will last 30 months. Potential participants must be able to attend weekly treatment sessions in Pittsburgh, PA.

The study design is a 30-month (2.5 years) randomized-controlled trial, where eligible participants will be randomized to the CET or EST study treatments. Participants will be treated with the study interventions for 18 months, and then followed for 12 additional months to assess the lasting impact of the study interventions. All participants will complete cognitive, clinical, and neuroimaging (magnetic resonance imaging) assessments prior to starting the study treatments and then at specified intervals thereafter to evaluate the impact of the study treatments on cognition, adaptive function, and the brain.

Study Design

Study Type:
Interventional
Actual Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
Actual Study Start Date :
Aug 1, 2010
Actual Primary Completion Date :
Apr 1, 2016
Actual Study Completion Date :
Jun 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cognitive Enhancement Therapy

This research treatment aims to help with problems in thinking, planning, and socialization. Participants begin with cognitive training using computer software programs. They also participate in a small social-cognitive group to learn about their condition and how to act wisely in social situations by developing the abilities needed to understand another person's perspective, evaluate social contexts, and be foresightful. Time commitment: about 3½ hours per week; Location: Pittsburgh, PA only

Behavioral: Cognitive Enhancement Therapy
An 18-month comprehensive, small group approach for the remediation of cognitive deficits in neurodevelopmental disorders consisting of individual sessions and 45 group training sessions in social cognition that are integrated with approximately 60 hours of computer assisted training in attention, memory, and problem solving skills.

Active Comparator: Enriched Supportive Therapy

This research treatment uses individual supportive therapy to help adults learn about autism spectrum disorder, manage their emotions and stress, improve their social skills, and cope with everyday problems. Participants will learn about the impact of stress on their lives, and how to identify their own early cues of distress and apply effective coping strategies. Time commitment: about 1 hour per week; Location: Pittsburgh, PA only

Behavioral: Enriched Supportive Therapy
An 18-month intervention that uses individual supportive therapy to help adults learn about autism spectrum disorder, manage their emotions and stress, improve their social skills, and cope with everyday problems. Participants will learn about the impact of stress on their lives, and how to identify their own early cues of distress and apply effective coping strategies.

Outcome Measures

Primary Outcome Measures

  1. Neurocognition [Pre-treatment, 9, 18, and 30 months]

    Composite measure of neuropsychological tests designed to assess neurocognitive function

  2. Social cognition [Pre-treatment, 9, 18, and 30 months]

    Composite measure of performance-based and interview tests designed to assess social-cognitive function

Secondary Outcome Measures

  1. Functional outcome [Pre-treatment, 9, 18, and 30 months]

    Functional Assessment Battery (Social, Role, Vocational)

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 16-45 years

  • Diagnosis of autism, Asperger's syndrome, or pervasive developmental disorder not otherwise specified (NOS) verified by the autism diagnostic observation schedule (ADOS) or autism diagnostic interview-revised (ADI-R)

  • Presence of significant social and cognitive disability, based on the Cognitive Style and Social Cognition Eligibility Interview (Hogarty et al., 2004)

  • Intelligence quotient (IQ) greater than 80

  • Ability to read and speak fluent English

  • Availability of a family member or close friend allowed to provide information on the participant

  • Ability to attend weekly treatment sessions in Pittsburgh, PA

Exclusion Criteria:
  • Organic brain syndrome

  • IQ < 80

  • English language skills below a sixth grade level

  • Persistent suicidal or homicidal behavior

  • History of substance abuse or dependence within the past 3 months

  • Comorbid attention deficit hyperactivity disorder (ADHD)

  • Comorbid personality disorder

  • History of disruptive or violent behavior

  • Any magnetic resonance imaging contraindications

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pittsburgh Pittsburgh Pennsylvania United States 15213

Sponsors and Collaborators

  • University of Pittsburgh
  • National Institute of Mental Health (NIMH)
  • Autism Speaks
  • United States Department of Defense
  • Pennsylvania Department of Health

Investigators

  • Principal Investigator: Shaun M. Eack, PhD, University of Pittsburgh
  • Principal Investigator: Nancy J. Minshew, MD, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Shaun M. Eack, Professor of Social Work and Psychiatry, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00902798
Other Study ID Numbers:
  • MH085851
  • R33MH085851
  • R21MH085851
  • AR100344
  • 05381
  • 2008NF-Autism
  • ARI2014
First Posted:
May 15, 2009
Last Update Posted:
Apr 13, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Shaun M. Eack, Professor of Social Work and Psychiatry, University of Pittsburgh
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 13, 2020